NuVasive | NUVA - Passifs Courants



Passifs Courants Changement Date
Abbott USD 16.5B 1.91B 2025-12
AtriCure USD 81.52M 3.68M 2025-12
Baxter International USD 2.97B 805M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.59B 183.3M 2025-09
Globus Medical USD 498.5M 32.54M 2025-12
Haemonetics USD 539.87M 8.45M 2025-12
Hologic USD 951.3M 25.9M 2025-12
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
Intuitive Surgical USD 2.52B 207.3M 2025-12
J&J USD 54.13B 3.26B 2025-12
Medtronic USD 9.94B 1.6B 2025-09
Merit Medical Systems USD 239.76M 9.29M 2025-12
Orthofix International USD 159.85M 11.47M 2025-09
Stryker USD 7.79B 380M 2025-12
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12